Cellectis
CLLS
#7329
Rank
A$0.69 B
Marketcap
A$6.77
Share price
3.06%
Change (1 day)
101.00%
Change (1 year)

Market capitalization of Cellectis (CLLS)

Market cap: A$0.69 Billion

As of January 2026 Cellectis has a market cap of A$0.69 Billion. This makes Cellectis the world's 7329th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Cellectis from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026A$0.69 B-2.88%
2025A$0.71 B207.65%
2024A$0.23 B-28.54%
2023A$0.32 B125.03%
2022A$0.14 B-72.78%
2021A$0.52 B-68.14%
2020A$1.65 B55.65%
2019A$1.06 B2.54%
2018A$1.03 B-19.53%
2017A$1.29 B53.7%
2016A$0.84 B-43.01%
2015A$1.47 B175.47%
2014A$0.53 B612.85%
2013A$75.06 M

End of Day market cap according to different sources

On Jan 6th, 2026 the market cap of Cellectis was reported to be:

A$0.47 Billion
by Nasdaq info icon info icon
A$0.65 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
uniQure
QURE
A$2.13 B 209.36%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Novavax
NVAX
A$1.84 B 166.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$128.00 B 18,424.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
A$0.68 B-1.25%๐Ÿ‡บ๐Ÿ‡ธ USA